SI1036062T1 - Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors - Google Patents

Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors

Info

Publication number
SI1036062T1
SI1036062T1 SI9830605T SI9830605T SI1036062T1 SI 1036062 T1 SI1036062 T1 SI 1036062T1 SI 9830605 T SI9830605 T SI 9830605T SI 9830605 T SI9830605 T SI 9830605T SI 1036062 T1 SI1036062 T1 SI 1036062T1
Authority
SI
Slovenia
Prior art keywords
mmp
inhibitors
acid derivatives
hydroxamic acid
matrix metalloprotease
Prior art date
Application number
SI9830605T
Other languages
Slovenian (sl)
Inventor
Kevin Neil Dack
Gavin Alistair Whitlock
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9725782.8A external-priority patent/GB9725782D0/en
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SI1036062T1 publication Critical patent/SI1036062T1/en

Links

SI9830605T 1997-12-05 1998-10-09 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors SI1036062T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9725782.8A GB9725782D0 (en) 1997-12-05 1997-12-05 Therapeutic agents
EP98955494A EP1036062B1 (en) 1997-12-05 1998-10-09 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
PCT/EP1998/006640 WO1999029667A1 (en) 1997-12-05 1998-10-09 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors

Publications (1)

Publication Number Publication Date
SI1036062T1 true SI1036062T1 (en) 2004-04-30

Family

ID=32178749

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830605T SI1036062T1 (en) 1997-12-05 1998-10-09 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors

Country Status (1)

Country Link
SI (1) SI1036062T1 (en)

Similar Documents

Publication Publication Date Title
IL136300A0 (en) Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
NZ304689A (en) Lactam-containing hydroxamic acid derivatives and use as matrix metalloprotease (mmp) inhibitors
IL144783A0 (en) Sulfamato hydroxamic acid metalloprotease inhibitor
DK0925303T3 (en) Phosphinic acid amides as matrix metalloprotease inhibitors
HUP0000641A3 (en) Ortho-sulfonamido aryl hydroxamic acid derivatives, their use, as matrix metalloproteinase and tace inhibitors and pharmaceutical compositions containing them
HK1040242A1 (en) Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
AU4201799A (en) Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
GB9401129D0 (en) Hydroxamic acid derivatives as metalloproteinase inhibitors
HK1045501A1 (en) Hydroxamic acid derivatives as matrix metalloprotease inhibitors
AU5634999A (en) Hydroxamic acid derivatives as proteinase inhibitors
AU6764400A (en) Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors
IL129420A0 (en) Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
HUP0101300A3 (en) Matrix metalloprotease inhibitors
AU2201701A (en) Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors
HRP970247A2 (en) Substituted 4-arylbutric acid derivatives as matrix metalloprotease inhibitors
SI1036062T1 (en) Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
AU5034699A (en) Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives andpeptide backbone modified derivatives thereof
GB2299335B (en) Hydroxamic acid derivatives as metalloproteinase inhibitors
SI1001930T1 (en) N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
GB9818830D0 (en) Hydroxamic acid derivatives as proteinase inhibitors
GB9320360D0 (en) Hydroxamic acid derivatives as metalloproteinase inhibitors
GB9305348D0 (en) Hydroxamic acid derivatives as metalloproteinase inhibitors